Purchase Order 75D30120P08607
- Not listed
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $180,772.01 firm-fixed-price purchase order to Revvity Health Sciences, Inc., a for-profit manufacturer of medical imaging products and services. The contract, which does not have a set-aside designation, is for the purchase of a CHEMAGIC 360 device to support the agency's Coronavirus COVID-19 response efforts. Revvity Health Sciences, Inc. is a subsidiary of Revvity Inc., which has previously...
- The Department of Health and Human Services Centers for Disease Control and Prevention (HHS CDC) awarded a firm fixed-price purchase order worth $137,053.70 to Revvity Health Sciences, Inc. for the PERKINELMER CHEMAGIC 360 INSTRUMENT. The contract, which had a completion date of July 30, 2021, was awarded on June 30, 2017. The place of performance was in Atlanta, Georgia. Revvity Health Sciences, Inc. is a for-profit manufacturer of medical imaging products and laboratory equipment that has...
- This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Revvity Health Sciences, Inc. for the acquisition of immunization laboratory equipment. The contract has a ceiling value of $108,296.29 and a period of performance through September 29, 2022. The original contract opportunity was a sole source award to Perkins Elmer for a Chemagic 360 instrument to replace an older Chemagic MSM1 system. The Chemagic 360 would be used in ongoing studies and...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $10,530.15 Firm Fixed Price Purchase Order to Revvity Health Sciences, Inc. for a PERKINELMER BIOQULE NGS AUTOMATED LIBRARY PREP INSTRUMENT. The contract has a completion date of September 1, 2023 and was awarded on August 25, 2023. This award does not appear to have a set-aside designation. Revvity Health Sciences, Inc. is a for-profit manufacturer of medical imaging products and services, and...
- The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order to Revvity Health Sciences, Inc. for the delivery of a SCICLONE G3 NGSX HT WORKSTATION laboratory instrument. The contract has a potential value of $242,491.55 and a period of performance through September 30, 2020. No set-aside designation was used for this award. Revvity Health Sciences, Inc. is a for-profit manufacturer that provides a range of medical...
- The Centers for Disease Control and Prevention awarded a firm fixed-price purchase order valued at $137,521.68 to Revvity Health Sciences, Inc. for a Zephyr G3 NGS liquid handler with an integrated ultraviolet light system. The original solicitation indicated the CDC intended to make a sole source award to PerkinElmer Health Sciences, Inc. for the equipment, citing specifications including compatibility with a small laboratory space, processing of 96 samples at once, and other features. No...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $249,015.99 firm-fixed-price purchase order contract to Revvity Health Sciences, Inc. for the PERKIN ELMORE-SCICLONE G3 NGSX medical imaging product. The contract will be performed in Shelton, Connecticut and has a completion date of October 15, 2022. Revvity Health Sciences, Inc. is a for-profit manufacturer of goods that provides a wide variety of medical devices and equipment, as well as...
- This is a federal contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Revvity Health Sciences, Inc. for the provision of laboratory equipment. The contract has a total potential value of $176,266.20 and is a Firm Fixed Price Delivery Order under the General Services Administration (GSA) Scientific Equipment and Services (FSS-66) schedule contract. The contract does not have a set-aside designation. Revvity Health Sciences is a...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $86,313 purchase order to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. Medical Imaging, LLC, for laboratory supplies. The firm fixed price contract runs from July 12, 2023 to October 13, 2023 for delivery of the requested products to the CDC location in Shelton, Connecticut. No subcontractors or set aside designations were identified. The award provides supplies to...
- This firm-fixed price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Revvity Health Sciences, Inc. in the amount of $245,517.00. The contract has a completion date of January 1, 2023 and does not include a set-aside designation. The contract provides medical imaging products and services to the CDC, likely in support of the agency's public health research and disease surveillance programs. Revvity Health Sciences,...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $226,845.75 firm-fixed-price purchase order to Revvity Health Sciences, Inc. for the delivery of CHERMAGIC 360 AND JANUS G3 QPCR WORKSTATION. This equipment supports the CDC's COVID-19 pandemic response efforts. The contract was awarded on June 16, 2020, with a completion date of August 10, 2020. The place of performance is Shelton, CT. Revvity Health Sciences, Inc. is a for-profit manufacturer that provides medical imaging products and services to federal agencies through prime contracts, subcontracts, and indefinite delivery vehicles (IDVs). The company's parent organization is Revvity Inc., which includes a Medical Imaging division that has previously supported federal agencies like the National Oceanic and Atmospheric Administration and the U.S. Department of Agriculture with laboratory equipment, automation applications, and liquid chromatography systems. This contract award did not utilize a small business set-aside.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $226.8k | 6/17/20 |